What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2023? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society.
Journal
Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144
Informations de publication
Date de publication:
18 Mar 2024
18 Mar 2024
Historique:
medline:
18
3
2024
pubmed:
18
3
2024
entrez:
18
3
2024
Statut:
aheadofprint
Résumé
The 2023 Joint Annual Congress of the International Liver Transplantation Society, European Liver and Intestine Transplant Association, and Liver Intensive Care Group of Europe were held in Rotterdam, the Netherlands, from May 3 to 6, 2023. This year, all speakers were invited to attend the Congress in person for the first time since the COVID-19 pandemic. The congress was attended by 1159 registered delegates from 54 countries representing 5 continents, with the 10 countries comprising the bulk of the delegates. Of the 647 abstracts initially submitted, 542 were eventually presented at the meeting, coming from 38 countries (mainly North America, Europe, and Asia) and 85% of them (462 abstracts) came from only 10 countries. Fifty-three (9.8%) abstracts, originated from 17 countries, were submitted under the Basic/Translational Scientific Research category, a similar percentage as in 2022. Abstracts presented at the meeting were classified as (1) ischemia and reperfusion injury, (2) machine perfusion, (3) bioengineering and liver regeneration, (4) transplant oncology, (5) novel biomarkers in liver transplantation, (6) liver immunology (rejection and tolerance), and (7) artificial intelligence and machine learning. Finally, we evaluated the number of abstracts commented in the Basic and Translational Research Committee-International Liver Transplantation Society annual reports over the past 5 y that resulted in publications in peer-reviewed journals to measure their scientific impact in the field of liver transplantation.
Identifiants
pubmed: 38494468
doi: 10.1097/TP.0000000000004980
pii: 00007890-990000000-00691
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no funding or conflicts of interest.
Références
Firl DJ, MacConmara M, Attia M, et al. Intentionally genome altered porcine livers perfused with human blood products can be sustained >72 hours ex vivo. Transplantation. 2023;107:282–283.
Ly M, Babekuhl D, Yousif P, et al. An experimental rodent model for long-term ex-vivo normothermic machine perfusion of livers. Transplantation. 2023;107:284–285.
Dengu F, Critchley W, Ceresa C, et al. Ex situ reperfusion injury/inflammation: immuno-molecular profiling of human livers during normothermic machine perfusion. Transplantation. 2023;107:4.
Panayotova GG, Qin Y, Lunsford KE, et al. Proteomic effluent analysis reveals down-regulation of novel inflammatory and transcriptional biomarkers following hypothermic oxygenated machine perfusion of liver allografts. Transplantation. 2023;107:38.
Dengu F, Lo Faro ML, Huang H, et al. Normothermic machine perfusion following prior static cold storage has a similar molecular profile to continuous NMP, with more sensitivity to ex situ reperfusion injury. Transplantation. 2023;107:40.
Lonati C, Dondossola D, Bertacco A, et al. Harnessing the beneficial effects of mesenchymal stem cells during liver machine perfusion: proof-of-concept of an advanced perfusion system coupled with a bioreactor. Transplantation. 2023;107:37–38.
Dengu F, Abbas H, Schofield J, et al. Removal of circulating nucleosomes/neutrophil extracellular traps (NETs) reduces ex-situ reperfusion injury in porcine DCD livers preserved with normothermic machine perfusion (NMP). Transplantation. 2023;107:123–124.
Filz von Reiterdank IC, Imbriani Bento R, Mojoudi M, et al. Genetic modification of rat liver using lentiviral vectors during ex vivo machine perfusion. Transplantation. 2023;107:80.
Huang J, Lau NS, Ly M, et al. Achieving long-term liver preservation: integration of a dialysis system to a commercial normothermic perfusion system. Transplantation. 2023;107:160.
Al-Adra D, Lan R, Jennings H, et al. Liver resident memory T cells are and normothermic liver perfusion. Transplantation. 2023;107.
Abbas SH, Shaheed S, Dengu F, et al. Hypoxia inducible factor modulation during normothermic machine perfusion (NMP) accelerates reduction in hepatic steatosis. Transplantation. 2023;107:132–133.
Kim J, Hong S-K, Yang Y, et al. Prediction of the degree of hepatic ischemia-reperfusion injury during normothermic machine perfusion based on the function of multidrug resistance-associated protein 2. Transplantation. 2023;107:129–130.
Bodewes S, Lascaris B, Adelmeijer J, et al. Normothermic machine-perfused human donor livers produce functional hemostatic proteins. Transplantation. 2023;107:136.
Torri F, Martinelli C, Bronzoni J, et al. Perfusate cytokines concentrations during liver grafts ex-situ normothermic perfusion (DCDNet study). Transplantation. 2023;107:137.
Ali K, Cazzaniga B, Liu Q, et al. Quantification of mitochondrial dysfunction surrogates in flushing solution to assess donor livers pre transplantation. Transplantation. 2023;107:200.
Rauter L, Schiefer J, Raeven P, et al. HOPE reduces shedding time of endothelial glycocalyx—its damage marker Syndecan-1 can predict early allograft dysfunction. Transplantation. 2023;107:23.
Clarke G, Mao J, Fan Y, et al. Evaluation of liver maximum capacity (LiMAx) measurements to monitor hepatocellular function during extended normothermic machine perfusion. Transplantation. 2023;107:84–85.
Lascaris B, Nijsten MW, Porte RJ, et al. The need for an artificial kidney for long-term NMP of human donor livers up to one week. Transplantation. 2023;107:176–177.
Clarke G, Mao J, Fan Y, et al. Development of an extended normothermic machine liver perfusion protocol. Transplantation. 2023;107:177.
Clarke G, Mao J, Fan Y, et al. N-acetylcysteine successfully meliorates methaemoglobin accumulation during extended normothermic machine liver perfusion. Transplantation. 2023;107:177–178.
Babekuhl D, Ly M, Kavehei O, et al. An add-on automated blood gas system for ex vivo normothermic machine perfusion. Transplantation. 2023;107:185.
Stevens L, Doppenberg J, Dubbeld J, et al. Optimization of ex vivo normothermic liver perfusion through the addition of (un)conjugated bile acid infusion. Transplantation. 2023;107:183.
Rivas E, Benitez J, Galaz V, et al. Hypothermic oxygenated perfusion (HOPE) using an ECMO device with FMN levels measurement and thermographic images for liver graft assessment and transplantation. Transplantation. 2023;107:189.
Obara H, Sato Y Y, Okazawa Y, et al. Liver assessment method with flow dynamics index during subnormothermic machine perfusion. Transplantation. 2023;107:192–193.
Yoshimoto S, Torai S, Kasamatsu H, et al. Impact of a novel flush method using environmental pressure control for organs from donor after cardiac death. Transplantation. 2023;107:193.
Ghinolfi D, Melandro F, Torri F, et al. Extended criteria grafts and emerging therapeutics strategy in liver transplantation. The unstable balance between damage and repair. Transplant Rev. 2021;35:100639.
Yang X, Li J, Liu J, et al. CXCR3+ hepatic natural killer cells promote hepatic ischemiareperfusion injury in liver transplantation. Transplantation. 2023;107:283.
Schlegel A, Porte R, Dutkowski P. Protective mechanisms and current clinical evidence of hypothermic oxygenated machine perfusion (HOPE) in preventing post-transplant cholangiopathy. J Hepatol. 2022;76:1330–1347.
Czigany Z, Lurje I, Schmelzle M, et al. Ischemia-reperfusion injury in marginal liver grafts and the role of hypothermic machine perfusion: molecular mechanisms and clinical implications. J Clin Med. 2020;9.
Ali K, Liu Q, Cazzaniga B, et al. Potential of mitochondrial dysfunction biomarkers during ex-vivo normothermic liver perfusion. Transplantation. 2023;107:90.
Clavien PA, Dutkowski P, Mueller M, et al. Transplantation of a human liver following 3 days of ex situ normothermic preservation. Nat Biotechnol. 2022;40:1610–1616.
Huang J, Lau N-S, Chung L, et al. Defining metabolic changes of human liver grafts during longterm normothermic machine perfusion. Transplantation. 2023;107:127.
Sampaziotis F, Muraro D, Tysoe OC, et al. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver. Science. 2021;371:839–846.
Willemse J, Bulut M, de Graaf MN, et al. A microfluidic bile-duct-on-a-chip platform for studying biliary epithelium in a dish. Transplantation. 2023;107:128.
Ly M, Lau N-S, Chen J, et al. Predicting the regenerative potential of human grafts with severebile duct injury. Transplantation. 2023;10789:3–4.
Nguyen-Lefebvre AT, Caldwell L, Barutcu S, et al. Single nucleus sequencing reveals hippo signaling as a key driver of human liver regeneration. Transplantation. 2023;107:134.
Nguyen-Lefebvre AT, Caldwell L, Barutcu S, et al. Single nucleus sequencing suggests decreased regenerative capacity in graft fibrosis post-liver transplantation. Transplantation. 2023;107:130.
Martin CA, Radhakrishnan S, Kalkura SN, et al. Rejuvenation of diseased liver using gelatin-based scaffolds – using the immunomodulatory property of mesenchymal stem cells. Transplantation. 2023;107:137.
Xie D, Zhang G, Ma Y, et al. Circulating metabolic markers related to the diagnosis of hepatocellular carcinoma. J Oncol. 2022;2022:7840606.
Fu L, Jiang Z, Li T, et al. Circular RNAs in hepatocellular carcinoma: functions and implications. Cancer Med. 2018;7:3101–3109.
Hu X, Chen R, Chen G, et al. CircRNA-regulated ubiquitination and phosphorylation underlies NCL-mediated tumor recurrence in liver transplant patients. Transplantation. 2023;107:38–39.
Pang L, Yeung OWH, Ng KTP, et al. Postoperative plasmacytoid dendritic cells secrete IFNalpha to promote recruitment of myeloid-derived suppressor cells and drive hepatocellular carcinoma recurrence. Cancer Res. 2022;82:4206–4218.
Pang L, Liu J, Ding T, et al. IFN-α-producing plasmacytoid dendritic cells drive hepatocellular carcinoma recurrence through IRF1/HDAC2/IDO1 axis after liver transplantation. Transplantation. 2023;107:6–7.
Zhan W, Zhu J, Wang Z, et al. Inactivation of histone deacetylase HDAC9 downregulates 53BP1 to promote invasion and metastasis of cholangiocarcinoma. Transplantation. 2023;107:42.
Badshah J, Aliwaisi A, Subramanian S, et al. Defining tumor-associated macrophages subpopulation in intrahepatic cholangiocarcinoma as prognostic and therapeutic targets. Transplantation. 2023;107:122–123.
Montano-Loza AJ, Rodriguez-Peralvarez ML, Pageaux GP, et al. Liver transplantation immunology: immunosuppression, rejection, and immunomodulation. J Hepatol. 2023;78:1199–1215.
Bruner J, Angeli-Pahim I, Mathur S, et al. Phenotypic personalized medicine to guide immunosuppression management in liver transplantation. Transplantation. 2023;107:28.
Abecassis M M, Levitsky J. Combined gene expression profile and donor derived cell free DNA: defining the future of biomarker informed immunosuppression minimization following liver transplantation. Transplantation. 2023;107:8.
Zubair H, Mas V, Azim S, et al. Non-invasive biomarkers for calcineurin inhibitor nephrotoxicity in liver transplantation. Transplantation. 2023;107:128–129.
Wang Y, Li P, den Hoed C, et al. The multifaceted impact of immunosuppressants on pancoronavirus infection. Transplantation. 2023;107:31.
Nieuwenhuis L, LI Y, Loza BL, et al. Genome-wide meta-analysis implicates donor-recipient non-HLA genetic mismatch with acute cellular rejection after liver transplantation. Transplantation. 2023;107:49.
Rocque B, Barbetta A, Bangerth S, et al. Interplay between intrahepatic macrophages and alloreactive and regulatory T-cells mediates the complex alloimmune microenvironment during acute rejection in clinical liver transplantation. Transplantation. 2023;107:80–81.
Hong SK, Han DK, Kim H, et al. Effect of maintenance anti-ICAM-1 antibody therapy in liver transplantation nonhuman primate models. Transplantation. 2023;107:36–37.
Sorbini M, Togliatto GM, Patrono D, et al. Donor cell-free DNA as an early marker of hepatic injury and failure after liver transplantation. Transplantation. 2023;107:52.
Connor A, Saharia A, Elaileh A, et al. Molecular profiling of cholangiocarcinoma post-liver transplantation informs precision medicine approaches. Transplantation. 2023;107:8–9.
Bhat M, Rabindranath M, Chara BS, et al. Artificial intelligence, machine learning, and deep learning in liver transplantation. J Hepatol. 2023;78:1216–1233.
Oh N, Choi G-S, Kim C. Artificial intelligence guided bile duct division during pure laparoscopic donor hepatectomy. Transplantation. 2023;107:24–25.
Abbas SH, Shaheed S, Lo Faro L, et al. Development of a ‘Liver Atlas’ using over 1,000 consecutive deceased donor livers to identify hepatic steatosis prior to retrieval. Transplantation. 2023;107:77–78.
Zhao X, Naghibzadeh M, Rahmani A, et al. Prediction of the unique disease trajectory of waitlisted patients with primary sclerosing cholangitis using machine learning algorithms. Transplantation. 2023;107:34.
Bangerth S, Ascher-Bartlett J, Jordan S, et al. Creation of the pediatric acute liver failure (PALF) Score to accurately predict survival with native liver. Transplantation. 2023;107:72.
Boteon YL, Attard J, Boteon A, et al. Manipulation of Lipid Metabolism During Normothermic Machine Perfusion: Effect of Defatting Therapies on Donor Liver Functional Recovery. Liver Transpl. 2019;25:1007–1022.
Bonaccorsi-Riani E, Gillooly AR, Iesari S, et al. Delivering siRNA Compounds During HOPE to Modulate Organ Function: A Proof-of-concept Study in a Rat Liver Transplant Model. Transplantation. 2022;106:1565–1576.
Bonaccorsi-Riani E, Gillooly A, Bruggenwirth IMA, et al. Delivery of genetic load during ex situ liver machine perfusion with potential for CRISPR-Cas9 gene editing: An innovative strategy for graft treatment. Hepatobiliary Pancreat Dis Int. 2021;20:503–505.
Bogensperger C, Hofmann J, Messner F, et al. Ex vivo mesenchymal stem cell therapy to regenerate machine perfused organs. Int J Mol Sci . 2021;22:5233.
Gilbo N, Blondeel J, Pirenne J, et al. Organ repair and regeneration during ex situ dynamic preservation: the future is Nano. Transpl Int. 2023;36:11947.